MARKET

REGN

REGN

Regeneron Pharmaceuticals
NASDAQ
714.89
+5.79
+0.82%
After Hours: 714.89 0 0.00% 18:04 05/08 EDT
OPEN
709.29
PREV CLOSE
709.10
HIGH
717.99
LOW
708.36
VOLUME
589.04K
TURNOVER
--
52 WEEK HIGH
820.12
52 WEEK LOW
474.60
MARKET CAP
74.95B
P/E (TTM)
17.42
1D
5D
1M
3M
1Y
5Y
1D
A Look At Regeneron Pharmaceuticals (REGN) Valuation After Otarmeni’s Accelerated FDA Approval
Simply Wall St · 1d ago
Assessing Regeneron (REGN) After Recent Share Price Weakness And Strong Valuation Signals
Simply Wall St · 2d ago
Analysts Offer Insights on Healthcare Companies: Joint (JYNT), Regeneron (REGN) and Collegium Pharmaceutical (COLL)
TipRanks · 2d ago
Is This Biotech Stock a Buy After a Groundbreaking Approval?
The Motley Fool · 2d ago
Regeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive Years
Barchart · 2d ago
Lilly and Regeneron Advance Obesity Combo Bet as Key Tirzepatide Trial Reaches Completion
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: BioCryst (BCRX) and Regeneron (REGN)
TipRanks · 3d ago
Analysts Are Bullish on These Healthcare Stocks: Geron (GERN), Regeneron (REGN)
TipRanks · 4d ago
More
About REGN
Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The Company is accelerating drug development using its proprietary technologies, such as VelociSuite, which produces optimized fully human antibodies and new classes of bispecific antibodies. VelociSuite consists of VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, VelociHum, and other related technologies. Its marketed products include EYLEA (aflibercept); Dupixent (dupilumab); Libtayo (cemiplimab); Ordspono (odronextamab); Kevzara (sarilumab); Itepekimab; Lynozyfic, and others.

Webull offers Regeneron Pharmaceuticals Inc stock information, including NASDAQ: REGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, REGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading REGN stock methods without spending real money on the virtual paper trading platform.